China Jo-Jo Drugstores (CJJD) Reports Q2 EPS of $0.04

China Jo-Jo Drugstores (NASDAQ: CJJD) reported Q2 EPS of $0.04, versus $0.00 reported last year. Revenue for the quarter came in at $20.2 million, versus $22.6 million reported last year.

Mr. Lei Liu, China Jo-Jo's Chairman and CEO, commented, "Our gross margin continued to expand, benefiting from more vendor rebates attributable to our focused marketing efforts in promoting brand-name pharmaceutical products, as we believe selling these products enhances our store popularity and customer loyalty. During the quarter, we achieved sales volume with certain brand pharmaceutical suppliers and received substantial rebates. In addition, now that the G20 summit is behind us, we have normalized our marketing activities and expect a rebound in retail sales in the third quarter."

For earnings history and earnings-related data on China Jo-Jo Drugstores (CJJD) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does
• Palogic urges Granite Point Mortgage to cut costs, halt new loans